Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

A Randomized, Double-Blind, Pilot Study of the Safety and Physiological Effects of Two Doses of BMN 110 in Patients With Mucopolysaccharidosis IVA (Morquio A Syndrome)

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT01609062
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:36:00.558600+00:00
Published At
2016-02-01T00:00:00+00:00
Record Updated At
2016-02-01
Results Posted At
2016-02-01
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Mucopolysaccharidosis IVA", "Morquio A Syndrome", "MPS IVA"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2016-02-01"
protocolSection.identificationModule.nctId
"NCT01609062"
protocolSection.identificationModule.officialTitle
"A Randomized, Double-Blind, Pilot Study of the Safety and Physiological Effects of Two Doses of BMN 110 in Patients With Mucopolysaccharidosis IVA (Morquio A Syndrome)"
protocolSection.statusModule.overallStatus
"TERMINATED"
protocolSection.designModule.phases
["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
"2016-02-01"

Study condition terms

  • Mucopolysaccharidosis IVA (protocolSection.conditionsModule.conditions)
  • Morquio A Syndrome (protocolSection.conditionsModule.conditions)
  • MPS IVA (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.